LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will participate on a panel entitled "Invest Globally: A Framework for Building Great Companies" at the CED's Globalization 2008 Conference
News | 02. 14. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.